ASX closes up 0.6%, banks, CSL, BHP gain
Iron ore futures -12% in 2 days, ASX 200 gives up early strong gains, closing 0.6 per cent higher. Bank stocks, plus CSL, BHP, South32 gain. Jobless rate fell to 4.5% but employment dived.
Csl
ASX recovers to end flat, RBA holds rates
The ASX recovered to finish steady after the RBA said the economy will ‘bounce back’ from Delta. Iron ore prices tumbled.
Corporate giants drag down ASX
The ASX closed in the red for the second straight day, with BHP trading ex-dividend knocking about 30 points off the index.
ASX ends 0.6% lower, BHP, CSL drop
ASX loses ground for second day, closing 0.6 per cent lower amid ex-dividend falls. Investors ditch BHP and CSL. Trade balance, home loans data higher.
ASX ends up 0.2%, Fortescue, South32 gain
The ASX 200 has closed 0.2 per cent higher, led by Fortescue Metals and South32. Iron ore giant’s profit more than doubled. Crown Resorts swings to loss, no dividend.
ASX ends up 0.4%, CBA, Afterpay gain
ASX 200 snaps five day losing streak to close 0.4 per cent higher, led by CBA and Afterpay. Ampol lobs Z Energy bid. Qantas offers rewards campaign for fully vaccinated passengers. Bitcoin hits $US50,000
‘ABV test’ threatens Australia’s mRNA vaccine push
In all its research, CSL – a global vaccination leader – had never heard of the “ABV test”. But it’s become a major stumbling block for the company in Australia.
‘Super jab’ is still out of reach: CSL
CSL chief executive Paul Perreault says it will be a big ask and misguided to combine Covid-19 and influenza vaccines into a single super jab.
Brits hold the key for BHP boss
If all goes to plan, BHP will be back at the top of the ASX 200 list with daylight between it and CBA or CSL.
BHP, CSL, Woodside weigh on ASX
ASX 200 closes down 0.1%. CSL, BHP, Woodside shares lower. Domino’s Pizza up 7%. Qantas makes jabs mandatory for workers.
Melbourne Uni’s Maskell named to CSL board
Duncan Maskell will join the CSL board, becoming one of the few university leaders to be a director of a major public company.
ASX hits record high, CSL gains
ASX 200 jumps to record high with most sectors up after positive leads from Wall Street and strong gains in CSL and banks, except for CBA.
A property injection for CSL’s boss
Its been almost 18 months since CSL boss Paul Perreault has laid foot in Australia, and with a growing alpine property portfolio we can see why.
‘Bad AGL’ could go private amid ESG pressure
For Peter Botten, the former longtime chief of oil and gas company Oil Search, the AGL demerger is driven by a double whammy of pressure.
World wants AstraZeneca vaccine: CSL
Biotech giant CSL insists that despite fading confidence about the AstraZeneca vaccine rollout, production at its Melbourne facility remains on track.
CSL sees strong recovery, but ‘herd immunity’ key
The best global investment pool in more than 20 years is making biotech giant CSL bullish about Australia’s post-pandemic recovery, but ‘herd immunity’ is key.
ASX gains 0.5% on US infrastructure deal
Australia’s shares shrugged off news of extended travel restrictions and a one week lockdown of four local government areas in Sydney, including the CBD and anyone who has worked there in the past 2 weeks.
ASX ends down 0.3% in choppy trading
Australia’s share market closed down 0.3% after a late bounce with banks and CSL continuing to drag on the market
NSW virus outbreak hurts Aussie stocks
The ASX took a hit as the ballooning Covid cluster in NSW hurt travel stocks and broader sentiment, while broker comments on CSL didn’t help.
ASX falls, CSL drags after downgrade
Stocks slid in early trade even after Wall Street extended its rally. Bitcoin fell below $US30,000 for first time in over five months. Costa raises for citrus buy.
Original URL: https://www.theaustralian.com.au/topics/csl/page/9